PFIZER’S RESPONSE TO PROJECT VERITAS’S STING FAILS TO CONVINCE:

There’s a lot of doublespeak and hiding behind language there. While Pfizer insists it performs no gain-of-function research, it goes on to admit that in a “limited number of cases,” the company engineers the COVID-19 virus to “enable the assessment of antiviral activity in cells.” That seems like it requires a lot more explanation, does it not? Because it seems to be somewhat in contradiction with their initial claim.

The real issue here is what is worth the risk and what isn’t. It’s not completely out of line for a pharmaceutical company to do research toward developing vaccines for possible variants. To completely frame that pursuit as nefarious would be to dismiss and discourage lots of positive research throughout the history of medicine.

With that said, it seems pretty clear, at least in my view, that Pfizer isn’t doing what it’s doing because they fear future variants, and with so many people already having been infected, the efficacy of more and more boosters remains in doubt anyway. COVID-19 vaccines and antivirals are what make Pfizer billions of dollars, and they have every incentive to keep shoving boosters out while insisting they are needed because of “variants.”

Their statement isn’t going to convince anyone on the fence. It’s obfuscatory and confusing at best, and given Pfizer’s history of misleading the public, there’s no reason to take the company’s word for anything.

True.